Coronary Artery Disease: A Key Issue in Type 2 Myocardial Infarction: Systematic Review and Recent Findings

Hermann Yao1,2, Marianne Zeller1, Roland N'Guetta2

  • 1PEC2, EA 7460, UFR Health Sciences, University of Bourgogne Franche Comté, 25000 Dijon, France.

PubMed

Insights

Coronary artery disease (CAD) plays a significant role in type 2 myocardial infarction (T2MI) pathophysiology. This review examines CAD

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pathophysiology

Background:

  • Type 2 myocardial infarction (T2MI) results from myocardial ischemia due to an oxygen supply/demand mismatch.
  • Coronary artery disease (CAD) is frequently observed in T2MI patients and is often more severe than in type 1 myocardial infarction (T1MI).
  • The specific mechanisms linking CAD to T2MI triggers and their prognostic implications remain incompletely understood.

Purpose of the Study:

  • To review the prevalence and severity of underlying CAD in T2MI.
  • To explore challenges in differentiating T2MI from T1MI when CAD is present.
  • To assess the prognostic significance of CAD in the context of T2MI.

Main Methods:

  • Literature review synthesizing existing research on T2MI and CAD.
  • Analysis of studies focusing on the pathophysiology, diagnosis, and outcomes of T2MI.
  • Examination of the interplay between non-coronary triggers, oxygen imbalance, and CAD severity.

Main Results:

  • CAD is a common and severe comorbidity in T2MI.
  • Distinguishing T2MI from T1MI can be challenging in the presence of significant CAD.
  • CAD significantly impacts both short-term and long-term prognosis in T2MI patients.

Conclusions:

  • Underlying CAD is a critical factor in T2MI, often underrecognized and undertreated.
  • Accurate assessment and management of CAD are essential for improving T2MI outcomes.
  • Further research is needed to elucidate the complex mechanisms and optimize treatment strategies for T2MI with CAD.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K